-
Moderna's gene therapy expansion picks up pace with $76M upfront Generation Bio collab— Disgraced former Seagen CEO tapped to lead MorphImmune less than a year after domestic assault arrest— Sanofi and Regeneron's Dupixent scores trial win in tough-to-treat COPD See more on our front page newsDismiss Notice
Why Amgen Is Up More Than 6% Today
Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Oct 11, 2022 at 4:22 PM.